In addition, within gliomas, our tool is able to determine the tumors type based on the metabolic profile with an acceptable accuracy rate allowing the prediction of prognosis-relevant parameters such as IDH-mutation and 1p19q-codeletion in a non-invasive manner. Here, IDH1 is linked to glioma.